Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Iovance Biotherapeutics (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

BTOG 2018 | Aiming for the NOLCP in Wales and HCP collaboration

This years’ British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland, presented a range of exciting data, with talks on a National Optimal Lung Cancer Pathway (NOLCP) for the UK a hot topic. Speaking from the meeting, Sarah Morgan, of Hywel Dda University Health Board, Carmarthen, UK, gives us her high points from the meeting. She highlights information on the NOLCP, commenting on lung cancer care in Wales, as well as the collaborative research which the meeting fosters.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.